Genomic Health, Inc. (GHDX): Price and Financial Metrics


Genomic Health, Inc. (GHDX): $63.44

-0.44 (-0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GHDX Stock Summary

  • GHDX's current price/earnings ratio is 44.63, which is higher than 83.63% of US stocks with positive earnings.
  • The price/operating cash flow metric for NA is higher than 85.42% of stocks in our set with a positive cash flow.
  • Over the past twelve months, GHDX has reported earnings growth of 194.66%, putting it ahead of 93.48% of US stocks in our set.
  • Stocks that are quantitatively similar to GHDX, based on their financial statements, market capitalization, and price volatility, are OMCL, OSIS, PCTY, QDEL, and SPSC.

GHDX Stock Price Chart Interactive Chart >

Price chart for GHDX

GHDX Price/Volume Stats

Current price $63.44 52-week high $90.18
Prev. close $63.88 52-week low $50.77
Day low $62.74 Volume 12,537,000
Day high $64.57 Avg. volume 586,356
50-day MA $69.75 Dividend yield N/A
200-day MA $67.25 Market Cap 2.38B

Genomic Health, Inc. (GHDX) Company Bio


Genomic Health provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company was founded in 2000 and is based in Redwood City, California.


GHDX Latest News Stream


Event/Time News Detail
Loading, please wait...

GHDX Latest Social Stream


Loading social stream, please wait...

View Full GHDX Social Stream

GHDX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 21.16%
5-year 118.53%
YTD N/A
2020 N/A
2019 0.00%
2018 88.33%
2017 16.37%
2016 -16.51%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7514 seconds.